The oversubscription and full exit confirm strong shareholder demand for MiniMed exposure. Watch for the final proration factor on October 14 and the subsequent MDT share return process. Post-separation, MDT's float will shrink by ~55M shares, a modest structural positive for EPS, but the key catalyst is MiniMed's standalone trading dynamics.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 13 $93.01entry
- T+1 · 5w ago +1.31%α +2.39% · $94.23
- T+5 · 28d ago +1.74%α +2.89% · $94.63
- T+20 · 7d ago +9.22%α +12.84% · $101.59
- T+24 · todayOpen
- T+60 · in 7w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medtronic announced preliminary results of its MiniMed exchange offer, confirming it was oversubscribed with 298,024,452 MDT shares tendered. Medtronic will exchange all of its remaining MiniMed stake (252,813,348 shares) for 55,032,401 MDT shares at the final exchange ratio of 4.5939, resulting in an estimated 18.3% proration factor. This marks the near-completion of Medtronic's full separation from MiniMed, with no retained MiniMed shares post-offer.
Key Facts
- Exchange offer oversubscribed: 298,024,452 MDT ordinary shares validly tendered
- Medtronic exchanging all remaining MiniMed interest: 252,813,348 MiniMed shares
- Final exchange ratio: 4.5939 MiniMed shares per MDT share
- Medtronic accepting 55,032,401 MDT shares in exchange
- Estimated proration factor: ~18.3% of tendered MDT shares accepted
- Final proration factor to be announced October 14, 2026
- Post-offer, Medtronic will retain zero MiniMed common stock
Financial Impact
Medtronic fully exiting its MiniMed stake, 252,813,348 MiniMed shares exchanged for 55,032,401 MDT shares. No cash consideration; all-stock exchange.
Risk Factors
- Proration factor may shift if guaranteed delivery shares fail to settle
- Post-separation MDT may face execution risk as a leaner entity
- MiniMed's independent performance could create volatility for former MDT holders now holding MMED
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001628280-26-065596 |
| Document: 0001628280-26-065596-index-headers.html | 0001628280-26-065596 |
| Document: 0001628280-26-065596-index.html | 0001628280-26-065596 |
| Document: 0001628280-26-065596.txt | 0001628280-26-065596 |
Track record
53 reports on MDT
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
- Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 15, 20264w ago 144 Neutral 3/10 Entry $95.45 Now $102.88 +7.78% settles Jan 12
- Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers